Acne Treatment Method, System and Device

• US 20100069898A1
• Filed: 09/04/2009
• Published: 03/18/2010
• Est. Priority Date: 02/25/2003
• Status: Abandoned Application

• Current Assignee: Channel Investments, LLC
• Original Assignee: TRIA Beauty Incorporated (Channel Investments, LLC)
• Inventors: O'Neil, Michael P., Reichert, Patrick V., Liu, Harvey I., Island, Tobin C., Grove, Robert E., Schuetz, Charles A., Weckwerth, Mark V.
• Application Number:
  US12/554,831
• Publication Number:
  US 20100069898A1
• Time in Patent Office: Days
• US Class Current: 606/9
• CPC Class Codes: A61B 18/203 applying laser energy to the outside of the body
• CPC Class Codes: A61B 2017/00057 Light
• CPC Class Codes: A61B 2017/00061 spectrum
• CPC Class Codes: A61B 2017/00066 intensity
• CPC Class Codes: A61B 2017/00172 Pulse trains, bursts, intermittent continuous operation
• CPC Class Codes: A61B 2017/00734 battery operated
• CPC Class Codes: A61B 2018/00005 Cooling or heating of the probe or tissue immediately surrounding the probe
• CPC Class Codes: A61B 2018/00452 Skin
• CPC Class Codes: A61B 2018/00476 Hair follicles
• CPC Class Codes: A61B 2018/00708 switching the power on or off
• CPC Class Codes: A61B 2018/00827 Current
• CPC Class Codes: A61B 2018/2261 with scattering, diffusion or dispersion of light
• CPC Class Codes: A61B 2090/065 for measuring contact or contact pressure
• CPC Class Codes: A61N 2005/007 for cooling the patient
• CPC Class Codes: A61N 2005/0644 Handheld applicators
• CPC Class Codes: A61N 2005/0652 Arrays of diodes
• CPC Class Codes: A61N 2005/0662 Visible light
• CPC Class Codes: A61N 5/0616 Skin treatment other than tanning
• CPC Class Codes: A61P 17/10 Anti-acne agents

Abstract

An acne treatment system, device and method includes optical visualization means for identifying areas of skin colonized by the P. acnes bacteria, and further comprises methods, techniques and apparatus for the reduction or elimination of such colonies through the use of light of a power density and wavelength configured to be absorbed by porphyrins produced by the bacteria, resulting in a quenching. Various alternative embodiments are disclosed, including eye safe embodiments, embodiments in which a treatment regimen is provided on a disposable cartridge, embodiments in which the authenticity of the cartridge is verified to ensure proper operation, as well as others.

Claims

1. A device for treating lesions caused by the P. acnes bacteria in humans comprises

a light source emitting light of a wavelength in the range of 380-500 nm and having a power density of approximately 0.4 Watts/cm² or greater,

an optical mixer, having an input and an output, for receiving the light from the light source at an input, and distributing that light across the output,

a diffuser for receiving light from the output of the optical mixer for distributing the light substantially uniformly across the diffuser, and

an output window for receiving light from the output of the optical mixer and adapted to transmit the light onto an area of human skin to be treated.

2. The device of claim 1 wherein the wavelength range is 400-420 nm.

3. The device of claim 1 wherein the output window is adapted to provide cooling to the skin.

4. The device of claim 1 wherein the light source provides light continuously during a treatment procedure.

5. The device of claim 1 wherein the light source comprises one or more LEDs.

6. The device of claim 1 wherein the light source comprises from one to eight LEDs.

7. The device of claim1 wherein the light source is a laser diode.

8. A method for identifying colonization of skin by the P. acnes bacteria comprising the steps of

illuminating a area of skin suspected of being colonized with light having a wavelength suitable to cause porphyrins produced by the P. acnes bacteria to fluoresce,

filtering the light reflected by the skin to isolate the fluorescence of the porphyrins.

9. A method for treating skin colonized by the P. acnes bacteria comprising

illluminating by painting an affected area of skin with light having a power density in the range of 0.3 watts/cm² to 1 watt/cm² and a wavelength of 390-430 nm for a cumulative period sufficient to deliver a cumulative daily dose to the skin in the range of 1-4 Joules/cm2,

illuminating by dwelling over an area of skin having a lesion caused by the P. acnes bacteria for a cumulative period sufficient to deliver a cumulative daily dose to the area having a lesion in the range of 20-40 Joules/cm², and

repeating one or both of the painting and dwelling steps on an as-needed basis.

10. The method of claim 9 wherein only the painting step is repeated.

11. The method of claim 9 wherein the painting and dwelling steps are both repeated daily for the first two weeks.

12. A method for authenticating plug-in modules comprising

storing a first portion of data in a plug-in device,

storing a second portion of data in a plug-in device,

storing a third portion of data in an internal device accessible only through a controller,

hashing the first, second and third portions.

13. A capacitive sensor for detecting the presence of skin comprising

an optical mixer having at least a metalized portion and

one or more capacitors electrically connected to the metallic portion, and

a controller responsive to changes in charge on the one or more capacitors and adapted to indicate the proximity of skin to the mixer.

14. Apparatus for reducing colonization of human skin by P. acnes bacteria comprising

a light source emitting light of a wavelength in the range of 380-500 nm and having a power density of approximately 0.4 Watts/cm² or greater,

an optical mixer, having an input and an output, for receiving the light from the light source at an input, and distributing that light across the output,

a diffuser for receiving light from the output of the optical mixer for distributing the light substantially uniformly across the diffuser and creating an apparent virtual source at the diffuser, such that the output of the apparatus is eye safe, and

an output window for receiving light from the output of the optical mixer and adapted to transmit the light onto an area of human skin to be treated.

15. A capacitive sensor for detecting the presence of skin comprising

a housing,

a metallic component at the front of the housing and adapted to be placed proximate to human skin during normal operation,

one or more capacitors electrically connected to the metallic component, and

a controller responsive to changes in charge on the one or more capacitors and adapted to indicate the proximity of skin to the metallic component.

16. A method of reducing thermal impedance in an optical device comprising

mounting one or more flip-chip mounted light sources on a thermally conductive substrate,

fastening the thermally conductive substrate to a heat sink, and

creating, by convection, a boundary lay of air.

17. A method of ensuring authenticity of a cartridge intended to be plugged into a host comprising

storing, in sequence, first and second portions of authentication data in logic internal to a host,

creating a first encrypted data store derived from the first and second portions of authentication data, such that the first encrypted data store exists uniquely within the host.

storing, in sequence, authentication data in a cartridge,

creating a second encrypted data store derived from the authentication data in the cartridge, such that the second encrypted data store exists uniquely within the cartridge, and

comparing data derived from the first and second encrypted data store to determine the authenticity of the cartridge.

18. In a dermatologic treatment device, a method for providing treatment regimens for management of the device comprising the steps of

providing a cartridge having stored thereon one or more treatment regimens appropriate for use by the dermatologic treatment device,

providing a receptacle for electrically connecting to the cartridge,

reading at least a portion of a treatment regimen stored on the cartridge,

causing the dermatologic treatment device to operate in accordance with the read portion of a treatment regimen.

19. The invention of claim 18 wherein one treatment regimen comprises a measure of time of use of the dermatologic treatment device.

20. The invention of claim 18 wherein one treatment regimen comprises a measure of time remaining before a predetermined maximum.